These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11581230)

  • 1. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.
    Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H
    J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.
    Muñoz C; Zulantay I; Apt W; Ortiz S; Schijman AG; Bisio M; Ferrada V; Herrera C; Martínez G; Solari A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4518-23. PubMed ID: 23836179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Yield of xenodiagnosis and PCR in the evaluation of specific chemotherapy of Chagas' disease in children].
    Solari A; Contreras MC; Lorca M; García A; Salinas P; Ortíz S; Soto A; Arancibia C; Schenone H
    Bol Chil Parasitol; 1998; 53(1-2):27-30. PubMed ID: 9830721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients.
    Chiaramonte MG; Frank FM; Furer GM; Taranto NJ; Margni RA; Malchiodi EL
    Acta Trop; 1999 Apr; 72(3):295-308. PubMed ID: 10232785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina].
    Streiger ML; del Barco ML; Fabbro DL; Arias ED; Amicone NA
    Rev Soc Bras Med Trop; 2004; 37(5):365-75. PubMed ID: 15361952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi GG; Rassi Junior A
    Rev Soc Bras Med Trop; 2002; 35(6):547-50. PubMed ID: 12612733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
    Altcheh J; Castro L; Dib JC; Grossmann U; Huang E; Moscatelli G; Pinto Rocha JJ; Ramírez TE;
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008912. PubMed ID: 33412557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Chagas' disease: diagnostic and clinical aspects.
    Freilij H; Altcheh J
    Clin Infect Dis; 1995 Sep; 21(3):551-5. PubMed ID: 8527542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
    Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina].
    Altcheh J; Biancardi M; Lapeña A; Ballering G; Freilij H
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():41-5. PubMed ID: 16482812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
    Aguiar C; Batista AM; Pavan TB; Almeida EA; Guariento ME; Wanderley JS; Costa SC
    Trop Med Int Health; 2012 Mar; 17(3):368-73. PubMed ID: 22212647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase].
    Silveira CA; Castillo E; Castro C
    Rev Soc Bras Med Trop; 2000; 33(2):191-6. PubMed ID: 10881133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Chagas disease: Quantification of Trypanosoma cruzi in peripheral blood and dejections of Triatoma infestans fed by xenodiagnosis in patients with and without cardiopathy.
    Apt W; Carrasco D; Fuentealba C; Canals M; Muñoz G; Saavedra M; Castillo JP; Zulantay I
    Acta Trop; 2019 Dec; 200():105167. PubMed ID: 31513762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.
    Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole].
    Ferreira Hde O
    Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.